Scarica l'app Stockscreener
5.18
1.17%
0.06
Dopo l'orario di chiusura:
5.00
-0.18
-3.47%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SCYX Giù?
Forum
Previsione
Frazionamento azionario
Scynexis Inc Borsa (SCYX) Ultime notizie
SCYNEXIS (NASDAQ:SCYX) Upgraded at Wall Street Zen - MarketBeat
SCYNEXIS (SCYX) investors CVI and Heights disclose 5.9% ownership stake - Stock Titan
Revenue per share of SCYNEXIS, Inc. – DUS:135 - TradingView
Free cash flow per share of SCYNEXIS, Inc. – DUS:135 - TradingView
SCYNEXIS, Inc. Earnings and Revenue – DUS:135 - TradingView
135 Forecast — Price Target — Prediction for 2027 - TradingView
Great Point Partners (SCYX) reports 9.99% beneficial stake in Scynexis - Stock Titan
Results: SCYNEXIS, Inc. Confounded Analyst Expectations With A Surprise Profit - simplywall.st
SCYX Maintained by Guggenheim -- Price Target Raised to $33.00 - GuruFocus
Guggenheim raises Scynexis stock price target to $33 on drug potential - Investing.com Canada
Adage Capital group (SCYX) discloses 1,041,824-share SCYNEXIS stake including warrants - Stock Titan
SCYNEXIS Inc (SCYX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Scynexis Inc earnings beat by $1.14, revenue topped estimates - Investing.com Nigeria
SCYX Looks 78.3% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus
Scynexis Q2 adjusted EPS misses estimate as sales decline 82.77% - scanx.trade
Scynexis: Q2 Earnings Snapshot - Yahoo Finance
SCYNEXIS Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
SCYNEXIS (NASDAQ:SCYX) Announces Quarterly Earnings Results, Beats Expectations By $1.14 EPS - MarketBeat
Scynexis Q2 swings to profit on warrant adjustment; advances drug studies - TradingView
Scynexis (NASDAQ: SCYX) lifts cash and pipeline with Q2 2026 moves - Stock Titan
SCYNEXIS, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
SCYNEXIS (SCYX) Earnings Date and Reports 2026 - MarketBeat
SCYNEXIS (NASDAQ:SCYX) Lowered to Strong Sell Rating by Wall Street Zen - MarketBeat
SCYNEXIS Inc expected to post a loss of 51 cents a shareEarnings Preview - TradingView
SCYNEXIS Inc. R (135.MU) insider ownership and holdings - Yahoo Finance Australia
SCYNEXIS Inc (SCYX) Stock News Today - TradingKey
SCYNEXIS (SCYX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Scynexis Deadline Alert - TMX Newsfile
Scynexis stock price target reiterated at $44.64 by Brookline - Investing.com Nigeria
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
SCYNEXIS Inc (SCYX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - tradingkey.com
SCYNEXIS Inc (SCYX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
SCYX|SCYNEXIS Inc|Price:3.560|Chg%:-0.170 - TradingKey
SCYNEXIS Inc (SCYX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SCYNEXIS Inc (SCYX) Balance Sheet - TradingKey
SCYNEXIS Inc (SCYX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
SCYNEXIS Inc (SCYX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SCYNEXIS Inc (SCYX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
SCYNEXIS, Inc. Revenue Breakdown – NASDAQ:SCYX - TradingView
SCYNEXIS, Inc. Revenue Breakdown – LSE:0L49 - TradingView
SCYNEXIS (SCYX) Slides 2.35% as Biotech Stock Tests Key Support LevelInsider Buying Alerts - dars.gov.et
Federated Hermes (SCYX) group discloses 4.03% Scynexis stake in amended 13G - Stock Titan
FEDERATED HERMES, INC. Acquires 55,207 Shares of SCYNEXIS Inc - GuruFocus
Federated Hermes (SCYX) files 13G/A showing 55,207 shares (4.45%) - Stock Titan
Enterprise value to EBIT forward of SCYNEXIS, Inc. – NASDAQ:SCYX - TradingView
Enterprise value to EBIT forward of SCYNEXIS, Inc. – FWB:135 - TradingView
Analysts Offer Insights on Healthcare Companies: SCYNEXIS (SCYX) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
SCYNEXIS (NASDAQ:SCYX) Is In A Strong Position To Grow Its Business - Sahm
Form DEF 14A Scynexis Inc For: 2 July By Investing.com - Investing.com Nigeria
SCYX Q1 2026 Earnings: EPS Misses Estimates Significantly; No Revenue ReportedEarnings Yield Analysis - po-news-eg.net
Scynexis: Buy Rating Reiterated as Rare Disease Pipeline Advances; $32 Price Target Maintained - TipRanks
Form 4 Scynexis Inc For: 30 June By Investing.com - Investing.com Nigeria
SCYNEXIS (SCYX) director receives new RSU and stock option grants - Stock Titan
SCYNEXIS (NASDAQ: SCYX) director gets RSU and option awards - Stock Titan
SCYNEXIS (SCYX) director Armando Anido granted stock units and options - Stock Titan
0.79%
5.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):